OR WAIT null SECS
The Mobius MyWay portfolio offers off-the-shelf and configured-to-order single-use assemblies.
MilliporeSigma launched the Mobius MyWay portfolio, a program that allows more flexibility, better supply predictability, and shorter lead times for single-use biopharmaceutical manufacturing systems. The portfolio helps minimize schedule disruptions and delays. Pilot plants benefit from faster assembly design and delivery to adjust to new and evolving needs in real-time. Contract manufacturing organizations benefit from more reliable lead times allowing for better planning, which helps ensure on-time product delivery, said the company in a press release.
MilliporeSigma’s portfolio offers a choice of off-the-shelf and configured-to-order assemblies, as well as fully customizable configurations. Assemblies available as part of the Mobius MyWay portfolio are used for safe and effective fluid management across upstream and downstream processes, from routine buffer and media prep, to critical premium aseptic process and final drug manufacturing.
Assemblies are segmented into three categories, each offering a different level of configuration flexibility:
Among the assemblies included in the Mobius MyWay portfolio are Mobius MIX systems and bags up to 1000 L, holding and transport vessels up to 3500 L, Lynx CDR sterile connectors, and single-use final formulation, filtration, and final fill assemblies.